Madrigal Pharmaceuticals (MDGL) had the highest return between October 1, 2022 and December 30, 2022 by a mid-cap US stock, returning 336.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Madrigal Pharmaceuticals (MDGL) | 10/1/2022 - 12/30/2022 | 336.6% |
Viking Therapeutics (VKTX) | 10/1/2022 - 12/30/2022 | 240.58% |
Immunovant (IMVT) | 10/1/2022 - 12/30/2022 | 213.05% |
Verona Pharma PLC ADR (VRNA) | 10/1/2022 - 12/30/2022 | 155.68% |
Roivant Sciences (ROIV) | 10/1/2022 - 12/30/2022 | 151.26% |
IAMGold (IAG) | 10/1/2022 - 12/30/2022 | 130.36% |
Biohaven Pharmaceutical (BHVN) | 10/1/2022 - 12/30/2022 | 117.21% |
RLX Technology (RLX) | 10/1/2022 - 12/30/2022 | 116.99% |
Oceaneering International (OII) | 10/1/2022 - 12/30/2022 | 107.72% |
F&G Annuities & Life (FG) | 10/1/2022 - 12/30/2022 | 100.1% |
Miniso Group Holding (MNSO) | 10/1/2022 - 12/30/2022 | 99.44% |
Wave Life Sciences (WVE) | 10/1/2022 - 12/30/2022 | 96.63% |
TG Therapeutics (TGTX) | 10/1/2022 - 12/30/2022 | 96.51% |
Kingsoft Cloud Holdings (KC) | 10/1/2022 - 12/30/2022 | 88.67% |
Transocean (RIG) | 10/1/2022 - 12/30/2022 | 75.38% |
Manchester United (MANU) | 10/1/2022 - 12/30/2022 | 75.28% |
Melco Resorts & Entertainment (MLCO) | 10/1/2022 - 12/30/2022 | 72.93% |
Axsome Therapeutics (AXSM) | 10/1/2022 - 12/30/2022 | 69.33% |
Turkcell Iletisim Hizmetleri AS (TKC) | 10/1/2022 - 12/30/2022 | 68.66% |
Powell Industries (POWL) | 10/1/2022 - 12/30/2022 | 65.54% |
HUTCHMED DRC (HCM) | 10/1/2022 - 12/30/2022 | 65.14% |
Tidewater (TDW) | 10/1/2022 - 12/30/2022 | 63.78% |
Arcellx (ACLX) | 10/1/2022 - 12/30/2022 | 63.57% |
Vipshop (VIPS) | 10/1/2022 - 12/30/2022 | 62.38% |
360 DigiTech (QFIN) | 10/1/2022 - 12/30/2022 | 60.39% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
